Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 26-May-22 5:28 PM View:  | Antares Pharma Inc. (ATRS) | 24-May-22 | Disposition | 386,132 | $5.60 | $2,162,340.00 | (83%) 467.58K to 81.44K | |
| 26-May-22 5:28 PM View: | Antares Pharma Inc. (ATRS) | 24-May-22 | Disposition | 1,800 | $5.60 | $10,080.00 | (2%) 81.44K to 79.64K | |
| 26-May-22 5:28 PM View: | Antares Pharma Inc. (ATRS) | 24-May-22 | Disposition | 79,645 | $5.60 | $446,012.00 | (100%) 79.64K to 0 | |
| 09-Jul-21 5:08 PM View: | Antares Pharma Inc. (ATRS) | 08-Jul-21 | Market Sale (Planned) | 100,000 | $4.29 | $429,000.00 | (18%) 567.58K to 467.58K | (< 1%) |
| 14-Jun-21 6:23 PM View: | Antares Pharma Inc. (ATRS) | 10-Jun-21 | Grant | 25,452 | $4.42 | $112,498.00 | 5% 542.13K to 567.58K | < 1% |
| 06-May-21 4:53 PM View: | Antares Pharma Inc. (ATRS) | 04-May-21 | Option Exercise | 40,000 | $1.66 | $66,400.00 | 8% 502.13K to 542.13K | |
| 03-May-21 5:56 PM View: | Antares Pharma Inc. (ATRS) | 29-Apr-21 | Option Exercise | 72,669 | $1.66 | $120,631.00 | 17% 429.46K to 502.13K | |
| 15-Jun-20 7:00 PM View: | Antares Pharma Inc. (ATRS) | 11-Jun-20 | Grant | 30,220 | $2.73 | $82,500.60 | 8% 399.24K to 429.46K | 41% |
| 15-May-20 4:30 PM View: | Antares Pharma Inc. (ATRS) | 13-May-20 | Option Exercise | 72,487 | $1.60 | $115,979.00 | 22% 326.75K to 399.24K | |
| 14-Jun-19 5:41 PM View: | Antares Pharma Inc. (ATRS) | 13-Jun-19 | Grant | 23,973 | $2.92 | $70,001.20 | 8% 302.78K to 326.75K | 32% |
| 21-Mar-16 9:14 AM View: | Antares Pharma Inc. (ATRS) | 18-Mar-16 | Market Purchase | 50,000 | $0.72 | $36,000.00 | 20% 252.78K to 302.78K | 455% |
| 08-Jan-16 5:31 PM View: | Neoprobe Corp. (NAVB) | 06-Jan-16 | Grant | 16,918 | $1.22 | $20,640.00 | 77% 22.0K to 38.92K | 66% |
| 06-Jul-15 12:26 PM View: | Neoprobe Corp. (NAVB) | 02-Jul-15 | Grant | 22,000 | $0.00 | $22.00 | 100% 0 to 22.0K | |
| 13-Aug-14 5:18 PM View: | Antares Pharma Inc. (ATRS) | 11-Aug-14 | Market Purchase | 5,000 | $2.00 | $9,999.50 | 2% 247.78K to 252.78K | 99% |
| 05-Sep-13 4:42 PM View: | Antares Pharma Inc. (ATRS) | 03-Sep-13 | Market Sale (Planned) | 25,000 | $4.42 | $110,570.00 | (9%) 270.98K to 245.98K | 10% |
| 05-Aug-13 4:40 PM View: | Antares Pharma Inc. (ATRS) | 01-Aug-13 | Market Sale (Planned) | 25,000 | $4.41 | $110,355.00 | (8%) 295.98K to 270.98K | 10% |
| 03-Jul-13 4:43 PM View: | Antares Pharma Inc. (ATRS) | 01-Jul-13 | Market Sale (Planned) | 25,000 | $4.15 | $103,685.00 | (8%) 320.98K to 295.98K | 4% |
| 03-Jul-13 4:44 PM View: | Antares Pharma Inc. (ATRS) | 01-Jul-13 | Market Sale (Planned) Duplicate | 25,000 | $4.15 | $103,685.00 | (8%) 320.98K to 295.98K | 4% |
| 03-Jul-13 4:44 PM View: | Antares Pharma Inc. (ATRS) | 01-Jul-13 | Market Sale (Planned) Duplicate | 25,000 | $4.15 | $103,685.00 | (8%) 320.98K to 295.98K | 4% |
| 05-Jun-13 4:39 PM View: | Antares Pharma Inc. (ATRS) | 03-Jun-13 | Market Sale (Planned) | 25,000 | $4.01 | $100,355.00 | (7%) 345.98K to 320.98K | < 1% |
| 24-May-13 4:44 PM View: | Antares Pharma Inc. (ATRS) | 22-May-13 | Grant | 27,778 | -- | -- | 9% 318.2K to 345.98K | |
| 21-Dec-12 6:57 PM View: | Spectrum Pharmaceuticals, I... (SPPI) | 19-Dec-12 | Grant | 10,000 | $11.34 | $113,400.00 | 1000% 1.0K to 11.0K | (67%) |
| 31-May-12 5:56 PM View: | Antares Pharma Inc. (ATRS) | 30-May-12 | Market Option Sale | 87,500 | $2.85 | $249,462.00 | (22%) 405.7K to 318.2K | (39%) |
| 31-May-12 5:55 PM View: | Antares Pharma Inc. (ATRS) | 29-May-12 | Payment of Exercise | 12,541 | $2.90 | $36,368.90 | (11%) 114.91K to 102.37K | (36%) |
| 31-May-12 5:56 PM View: | Antares Pharma Inc. (ATRS) | 29-May-12 | Payment of Exercise | 156,269 | $2.90 | $453,180.00 | (28%) 561.97K to 405.7K | (36%) |
| 31-May-12 5:55 PM View: | Antares Pharma Inc. (ATRS) | 29-May-12 | Option Exercise | 33,000 | $1.10 | $36,360.00 | 40% 81.91K to 114.91K | |
| 31-May-12 5:56 PM View: | Antares Pharma Inc. (ATRS) | 29-May-12 | Option Exercise | 459,594 | $0.99 | $453,189.00 | 449% 102.37K to 561.97K | |
| 21-May-12 4:49 PM View: | Antares Pharma Inc. (ATRS) | 17-May-12 | Grant | 30,914 | -- | -- | 61% 51.0K to 81.91K | |
| 28-Sep-10 10:15 AM View: | Antares Pharma Inc. (ATRS) | 27-Sep-10 | Market Purchase | 8,000 | $1.41 | $11,280.00 | 18% 44.0K to 52.0K | 181% |
| 18-May-09 6:24 PM View: | Antares Pharma Inc. (ATRS) | 15-May-09 | Market Purchase | 1,000 | $0.60 | $600.00 | 2% 43.0K to 44.0K | 421% |
| 10-Mar-04 10:00 PM View: | Antares Pharma Inc. (ATRS) | 09-Mar-04 | Grant | 25,000 | $1.00 | $25,000.00 | 167% 15.0K to 40.0K |